demonstrated that the addition of AURKA inhibitor VIC-1911 to KRAS inhibitor sotorasib led to increased cell death in resistant cancer cells compared to sensitive ones, suggesting that AURKA inhibition may overcome sotorasib resistance. The gene discussed is AURKA; the disease is cancer.